SCHEMBL24313753

SCHEMBL24313753

CCOc1ccccc1S(=O)(=O)NC(=O)c1cc2c(F)cc(C3CC3)cc2o1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 3/20 0.38
ALDH1A1 P00352 3/20 0.37
HTT P42858 2/20 0.37
HSD17B10 Q99714 1/20 0.37
GAA P10253 1/20 0.36
MRGPRX1 Q96LB2 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSPO P30536 1/20 0.36
RORC P51449 1/20 0.36
LMNA P02545 3/20 0.35
TSHR P16473 1/20 0.35
KAT6A Q92794 2/20 0.35
FABP4 P15090 1/20 0.35
TP53 P04637 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24313965 0.93 LMNA (0.38) MEN1KMT2AALDH1A1GAAMRGPRX1
SCHEMBL24314237 0.92 MRGPRX1 (0.38) MEN1KMT2AMRGPRX1L3MBTL1TSPO
SCHEMBL24313659 0.92 MRGPRX1 (0.36) MEN1KMT2AMAPTMRGPRX1L3MBTL1
SCHEMBL24314247 0.91 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL29588657 0.89 KAT6A (0.36) KAT6AFABP4
SCHEMBL24313760 0.89 SCN9A (0.35) MEN1KMT2AALDH1A1HSD17B10L3MBTL1
SCHEMBL29588075 0.89 HIF1A (0.37) MEN1KMT2AMAPTGAAMRGPRX1
SCHEMBL24314230 0.89 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL29588098 0.89 KAT6A (0.36) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL24314201 0.88 PTGER4 (0.39) MEN1KMT2AMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP claimed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed